Events

This meeting will examine the 'exceptional' nature of genomics and genomic information. After reviewing scientific advances, such as low cost genome wide scanning and population based research which links gene variants with common diseases such as cancer and heart disease, as well as some implications for global health, it will analyse how these evolving technologies might be used by industry.

Developments in genomic medicine formed the subject of a recent review by the House of Lords Science and Technology Subcommittee, whose report is due to be published in the spring. The meeting will consider some of the themes that emerge from this report and some implications for regulation and policy. It will then evaluate how regulators have sought to accommodate the changing perception of genes within their practice and will go on to examine how other types of information (such as family history) can be used in clinical care as a predictor of disease. Finally there will be consideration of how both genomic and family history information can be used by third parties such as insurers.

This three-day workshop gives participants the opportunity to work with world-leading experts in the field of human embryonic stem cell biology and gain practical experience of the culture and basic analysis of hES cells using a variety of cell lines. Laboratory practicals are supplemented with lectures of underlying concepts, the latest findings and the legal/ethical considerations in this fast moving field. The course includes a social event and ample opportunity for participants to discuss their research projects and plans with faculty and to investigate potential collaborations.

This course is limited to 16 students and provides detailed hands-on practical training in the maintenance of human embryonic stem cells. A protocol handbook and training DVD will be provided.